V
Volumina Medical
Develops injectable 3D scaffolds for the reconstruction of volumes of soft tissues
About Volumina Medical
Volumina Medical is a Swiss-based startup that operates in the healthcare sector, specifically in the field of reconstructive surgery. The company has developed a product called AdiPearl™, a result of extensive research conducted at the Swiss Federal Institute of Technology Lausanne (EPFL). This product is designed to provide minimally invasive solutions for soft tissue volume reconstruction, a need that was identified through interactions with surgeons.
Read full description
AdiPearl™ is a unique product that can be injected into the body in a safe and minimally invasive procedure. It is as soft as natural soft tissue and can be shaped upon injection, making it a versatile solution for a variety of reconstructive needs. This innovative product has been recognized multiple times for its disruptive technology and high market potential.
Volumina Medical's business model revolves around the development, production, and sale of AdiPearl™ to healthcare providers, primarily surgeons. The company generates revenue through the sale of this product, which is used in surgical procedures to reconstruct soft tissue volumes.
The market for Volumina Medical's product is vast, given the widespread need for reconstructive surgeries across the globe. The company's disruptive technology has the potential to revolutionize this market, providing a safer, less invasive, and more effective solution for soft tissue reconstruction.
At a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Epalinges, Switzerland
- Employees
- 12
- Open positions
- 1
- Dealroom signal
- 71.4/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, medical implants, Surgery, Plastic Surgery, Spinout, Start-Up Rescue Instrument (EIT Health), Start-Up Rescue Instrument 2020 (EIT Health), EIT Health, Woman Founder
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning Volumina Medical.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2024 | $21M | $84M | Undisclosed | ↗ |
| GRANT✓Other financing | Apr 2023 | $0 | — | Innosuisse | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Volumina Medical is 130 monthly website visits, down 72.9% over the last three months. Volumina Medical's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Venture Kick
EIT Health
Biopole
Innosuisse
Series A3 investors entered at this stage
Fondation FIT
Skyviews Life Science
Clinique La Prairie
Other known investors3 additional known investors
EPFL Swiss Federal Polytechnic School of Lausanne
Blue Ocean Ventures
VentureLab
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Volumina Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Volumina Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.